companydata.dkcompanydata.dk

VELIN-PHARMA A/S: Financial statements 2026

CVR: 33026013

Source: annual report 2026, Danish Business Authority

01/06/2025 – 31/05/2026

VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 33,996 and a net result of DKK -4,856,473 compared with DKK -16,021,366 the year before. That is a decrease of 64.2% compared with the year before. Equity in the 2026 report amounted to DKK 28,606,185. The solvency ratio was 90.1%.

Gross Profit
DKK 33,996
Profit/Loss
DKK -4,856,473
Equity
DKK 28,606,185
Total Assets
DKK 31,764,275
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-34K-4.9M28.6M0
2025-95K-16M33.5M0
2024--3K12.7M49.5M0
2023-161K5.5M36.8M0
2022-440K3.1M31.2M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like VELIN-PHARMA A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

About VELIN-PHARMA A/S

VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 33,996 and a net result of DKK -4,856,473 compared with DKK -16,021,366 the year before. Equity in the 2026 report amounted to DKK 28,606,185.

Source: annual report 2026, Danish Business Authority